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Supplementary Materials and Methods
Sample processing
Peripheral blood mononuclear cells (PBMC) were isolated from blood samples by density gradient centrifugation (Ficoll-Paque; GE Healthcare) and cryopreserved in aliquots until needed for in vitro assays.
Antibodies, buffer and peptide concentration for BH3 profiling
Antibodies used were anti-CD4 Pacific blue (clone RPA-T4; BD Biosciences), anti-CD25 PE-Cy7 (clone M-A251; BD Biosciences), anti-CD127 APC eFluor780 (clone eBioRDR5; eBioscience) and anti-CD8 PE/Cy5 (clone RPA-T8; BioLegend). T-EB Buffer contains 300 mM trehalose, 10 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, 80 mM potassium chloride, 1 mM ethyleneglycoltetraacetic acid, 1 mM ethylenediaminetetraacetic acid, 0.1% BSA and 5 mM succinic acid in distilled water at pH 7.4. BH3 peptide concentrations: BIM 10 µM, (C) TMRE staining in a patient with cGVHD. TMRE staining after challenge with Bmf was relatively lower in the patient with cGVHD than either healthy donor or patient without GVHD.
